Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2004

Jun 3, 2004

6965_dirs_2004-06-03_c357e88e-55d6-4e02-8a29-7f888bf225ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IGUANA VENTURES LTD (IGVL)
CIK: 0001176309
Period of Report: 2004-05-27

Reporting Person: Jeon Alex S (Director, President)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct